| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10213305 | International Journal of Cardiology | 2018 | 24 Pages |
Abstract
Almost one third of ACS patients have prasugrel contraindications and they have worst in in-hospital and post-discharge prognosis. Ticagrelor improved postdischarge outcomes in patients with prasugrel contraindications.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alberto Cordero, Jose M. GarcÃa-Acuña, Moisés RodrÃguez-Mañero, Rosa Agra-Bermejo, Belen Cid, Belen Alvarez, Vicente Bertomeu-González, Lorenzo Fácila, Vicente Bertomeu-MartÃnez, Jose R. González-Juanatey,